LEIDY CARABALLO GALVA

Concepts (20)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Hepatocellular
2
2021
985
0.730
Why?
Liver Neoplasms
2
2021
1381
0.650
Why?
Immunotherapy
1
2020
745
0.430
Why?
Immunotherapy, Adoptive
1
2020
897
0.390
Why?
Glypicans
1
2021
39
0.180
Why?
T-Lymphocytes
2
2020
1738
0.170
Why?
alpha-Fetoproteins
1
2020
134
0.150
Why?
Xenograft Model Antitumor Assays
1
2021
990
0.150
Why?
Cancer Vaccines
1
2020
188
0.140
Why?
Receptors, Antigen, T-Cell
1
2020
491
0.130
Why?
Antibodies, Monoclonal
1
2021
1028
0.120
Why?
Mice
2
2021
18507
0.070
Why?
Animals
2
2021
34882
0.050
Why?
Humans
3
2021
132132
0.040
Why?
HLA-A2 Antigen
1
2020
26
0.040
Why?
Pyrophosphatases
1
2020
22
0.040
Why?
Phosphoric Diester Hydrolases
1
2020
69
0.040
Why?
Cross Reactions
1
2020
189
0.040
Why?
Lymphocyte Activation
1
2020
678
0.030
Why?
Cells, Cultured
1
2020
3036
0.030
Why?
CARABALLO GALVA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (20)
Explore
_
Similar People (60)
Explore
_